866-997-4948(US-Canada Toll Free)

Published on : Oct 16, 2014

An experimental Ebola drug has been sent to Africa for use by Chinese aid worker by a Chinese drug manufacturer. The company is plans to undertake clinical trials of the drug to combat the deadly Ebola outbreak in West Africa that has claimed more than 4000 lives so far.

Several thousand doses of the drug JK-05, manufactured by Sihuan Pharmaceutical Holdings Group Ltd, have been supplied by the company to the affected area. The company has also informed that it can source more doses if necessary.

Global drugmakers and governments across the whole world have been in the attempts to find an effective medicine to combat the worst Ebola outbreak on record, having already claimed more than 4000 lives, and is also spreading in other parts of the world. Patients have so far found in the U.S. and the Europe. U.S. president Barack Obama has pledged to take more aggressive measure to fight Ebola.

Sihuan's assistant general manager, Huo Caixia, has stated that the drug has already been taken by aid workers, and if a case of Ebola occurs amongst the aid workers, the drug may be used.
 
Sihuan is a company partly owned by Morgan Stanley, the U.S. investment bank. It is hoping to get the dug approved in a fast track manner for use commonly in China. The company has sought an approval from the Academy of Military Medical Sciences (AMMS), to seek approval for use of the drug in China and bring it to the larger global market.

The drug has been approved in China for emergency military use only. It was originally developed by the AMMS. If the drug proves effective against the deadly Ebola outbreak, it would represent a huge success of China’s medical sector.